Therapeutic effects of CPU 86017 on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats

Drug Development Research

Volumn 63, Issue 1, 2004, Pages 22-32

  Wang, Yong Qing ^a   Shi, Yan Ping ^a   Dai, De Zai ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Captopril; CPU 86017; Endothelin 1 (ET 1); Heart failure; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATRIAL NATRIURETIC FACTOR; BERBERINE DERIVATIVE; CAPTOPRIL; CPU 86017; ENDOTHELIN 1; LACTATE DEHYDROGENASE; MALONALDEHYDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; P CHLOROBENZYL TETRAHYDROBERBERINE CHLORIDE; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VISCOSITY; CHRONIC DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CREATINE KINASE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART PERFORMANCE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; SHEAR RATE; SYSTOLIC BLOOD PRESSURE;

EID: 11344272368     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10383     Document Type: Article

References (28)

1. Chris MT. 2001. Mediators of chronic heart failure: how drugs work. Ann Pharmacother 35:1066-1074.
2. Dai DZ. 1997. The anti-arrhythmic activity of Protoberbreine in relation to blockade of ion channels. Ion. Channel Modulat 2:383-390.
3. Dai DZ, Jiang JM. 1998. p-Chlorobenzyltetrahydroberberine inhibits vascular smooth muscle contractions caused by Ca2+. Zhongguo Yao Li Xue Bao 19:543-547.
4. Dai DZ, Rong P, Huang J, et al. 1991. Anti-arrhythmic activities of six indole derivatives of changrolin. Acta Pharmacol Sin 12:411-415.
5. Dai DZ, Zong JG, Lei HY, Bai MQ, Rong P. 1995. Changes of superoxide dismutase, malondialdehyde, creatine phosphokinase in non-infarcted zone of an infarcted heart in rats and drug treatment. J Chin Pharmaceut Univ 26:291-296.
6. Dai DZ, Yu F, Li HT, et al. 1996. Blockade on sodium, potassium and calcium channels by a new antiarrhythmic agent CPU-86017. Drug Dev Res 39:138-146.
7. Dai DZ, He Y, Huang FH, Zhu Y, Khan HH. 2000. Comparison of inhibitory activity of Berberine derivative CPU 86017 and Berberine on vascular contractions. J Chin Pharmaceut Univ 31:447-450.
8. Dai DZ, Hu HJ, Zhao J, Hao XM, Yang DM, Zhou PA, Wu CH. 2004. Blockade of L-type calcium channel in myocardium and calcium-induced contractions of vascular smooth muscle by CPU 86017. Acta Pharmacol Sin 25:416-423.
9. Ding SS, Qiu CB, Hess P, et al. 2002. Chronic endothelin receptor blockade prevents renal vasoconstrction and sodium retention in rats with chronic heart failure. Cardiovasc Res 53:963-970.
10. Fukuchi M, Hussain SNA, Giaid A. 1998. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion site and β-adrenergic receptor therapy. Circulation 98:132-139.
11. Hare JM, Givertz M, Creager MA, Colucci WS. 1998. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of β-adrenergic inotropic responsiveness. Circulation 97:161-166.
12. Hong Y, Hui SC, Chan TY, Hou JY. 2002. Effect of berberine on regression of pressure-overload induced cardiac hypertrophy in rats. Am J Chin Med 30:589-599.
13. Hong Y, Hui SS, Chan BT, Hou J. 2003. Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy. Life Sci 72:2499-2507.
14. Jay NC, Roberto F, Norman S. 2000. Cardiac remodeling: concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 35:569-582.
15. John MM, Marc AP. 2002. New therapeutic options in congestive heart failure: Part I. Circulation 105:2099-2106.
16. Kinugawa S, Tsutsui H, Hayashidani S, et al. 2000. Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress. Circ Res 87:392-398.
17. Kobayashi N, Horinaka S, Mita S, et al. 2002. Aminoguanidine inhibits mitogen-activated protein kinase and improves cardiac performance and cardiovascular remodeling in failing hearts of salt-sensitive hypertensive rats. J Hypertens 20:2355-2356.
18. Laas J, Campbell CD, Takanashi Y, Pick RL, Replogle RL. 1980. Failure of intra-aortic balloon pumping to reduce experimental myocardial infarct size in swine. J Thorac Cardiovasc Surg 80:85-93.
19. Lau CW, Yao XQ, Chen ZY, Ko WH, Huang Y. 2001. Cardiovascular actions of berberine. Cardiovasc. Drug Rev 19:234-244.
20. Li HT, Wang YQ, Dai DZ, Kong RZ. 2001. Frequency dependent prolongation of effective refractory period by a complex class III antiarrhythmic agent CPU-86017. Acta Pharmacol Sin 22:32-36.
21. Ma YP, Hao XM, Zhang GQ, Zhou PA, Wu CH, Dai DZ. 2000. Blocking effect of CPU 86017 on slowly activated rectifier potassium current in single ventricular myocytes of guinea pig. J Chin Pharmaceut Univ 21:121-125.
22. Maki T, Nasa Y, Yamaguchi F, et al. 2001. Long-term treatment with neutral endopeptidase inhibitor improves cardiac function and reduces natriuretic peptides in rats with chronic heart failure. Cardiovasc Res 51:608-617.
23. Miller AB, Srivastava P. 2001. Angiotensin receptor blockers and aldosterone antagonists in chronic heart failure. Cardiol Clin 19:195-202.
24. Nakamura R, Egashira K, Machida Y, et al. 2002. Probucol attenuates left ventricular dysfunction and remolding in tachycardia-induced heart failure: role of oxidative stress and inflammation. Circulation 106:362-367.
25. Saavedra WF, Paolocci N, John MES, et al. 2002. Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. Circ Res 90:297-304.
26. Sia YT, Lapointe N, Parker TG, et al. 2002. Beneficial effects of long-term use of the antioxidant Probucol in heart failure in the rat. Circulation 105:2549-2555.
27. Takimoto Y, Aoyama T, Keyamura R, et al. 2000. Differential expression of three types of nitric oxide synthase in both infracted and non-infarcted left ventricles after myocardial infarction in the rat. Intern J Cardiol 76:135-145.
28. Zeng XH, Zeng XJ, Li YY. 2003. Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 92:173-176.